CCP110 and breast carcinoma: To assess whether miR-129-3p directly regulates CP110 expression through target sites in the 3′ UTR of CP110 mRNA in breast cancer cells, we cloned the CP110 3′ UTR region with wild-type or mutant miR-129-3p binding sites into the pMIR-REPORT vector.